Santero Therapeutics

Website
Current Valuation
$13.3M
As of March 11, 2025
Total Funding Raised
$9.9M
Last Round
Early Stage VC

$8.6M

Last Funding
Mar 2025

Funding date

Capital Efficiency
1.35x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Santero Therapeutics is currently valued at $13.3M as of March 11, 2025. The company has raised a total of $9.9M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.35x, Santero Therapeutics has achieved a valuation that is 1.35 times the total capital raised.

Track Santero Therapeutics Valuation Updates

Get notified when Santero Therapeutics raises new funding or valuation changes

Explore More Data
Detailed analysis for Santero Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Santero Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Santero Therapeutics Worth in 2026?

Santero Therapeutics is a leading private company in the technology sector. Track Santero Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Santero Therapeutics Valuation is Determined

Private company valuations like Santero Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.